Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Revenue

Betta Pharmaceuticals had revenue of 934.36M CNY in the quarter ending September 30, 2026, a decrease of -5.23%. This brings the company's total for the last twelve months to 3.80B, up 16.47% year-over-year. In the year 2025, Betta Pharmaceuticals had annual revenue of 3.61B with 24.81% growth. That makes Betta Pharmaceuticals the 10,521st largest company in the world by revenue and 1,736th in China.

• Revenue (ttm): 3.80B
• Revenue Growth: +16.47%
• P/S Ratio: 4.46
• Revenue / Employee: 2.13M
• Employees: 1,785
• Market Cap: 16.98B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 3.59B 99.4%
• Foreign 20.78M 0.6%

Fiscal year ended Dec 31, 2025 See the full Betta Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.61B	717.39M	24.81%
Dec 31, 2024	2.89B	435.75M	17.74%
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error